SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Cleopatra

PatientCleopatra
Date of birth1997-01-15
IdentifiersMRN HR-AC003-SYN; SSN (made up) 000-03-7095
Document date2026-06-23
AuthorNefeli Arvanitis-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Prenatal visit at 25 weeks with the growth scan and glucose challenge. [S]

History of Present Illness

Cleopatra returns at 25 weeks 0 days. The gastroenteritis three weeks ago settled within two days with oral fluids, and the tightenings stopped with it; she has had none since. Both babies move often. She takes aspirin, the prenatal vitamin, and ferrous sulfate every other day. She has no headache, visual change, swelling of the face or hands, bleeding, leaking fluid, or urinary symptoms. She is still working full days but has moved most of her meetings to the mornings and rests in the afternoon. She had the growth scan and the glucose challenge this morning. [S]

ElementDetail
GastroenteritisResolved within two days; no tightenings since
Fetal movementBoth babies moving often
WorkFull days with an afternoon rest
Tests todayGrowth scan, glucose challenge, blood count

Review of Systems

SystemResultFinding
ConstitutionalNegativeWell
NeurologicalNegativeNo headache or visual change
GenitourinaryNegativeNo bleeding, leaking fluid, or urinary symptoms
ObstetricNegativeNo tightenings or pelvic pressure
PsychiatricNegativeMood steady; EPDS 7

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-03activeS
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other dayOne tablet every other morning with water or orange juice, apart from tea, coffee, and calciumOral route2026-03-03activeS
Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtimeTwo tablets at bedtime; may add one in the morning if neededOral route2026-03-03 to 2026-05-12completedS
Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtime from 12 weeks until deliveryOral route2026-03-24activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-23Body height165cmS
2026-06-23Body weight64.2kgS
2026-06-23Body mass index (BMI) [Ratio]23.6kg/m2S
2026-06-23Systolic blood pressure108mm[Hg]S
2026-06-23Diastolic blood pressure66mm[Hg]S
2026-06-23Heart rate90/minS
2026-06-23Respiratory rate16/minS
2026-06-23Body temperature36.7CelS
2026-06-23Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-23Hemoglobin [Mass/volume] in Blood10.9g/dL10.5-15 g/dLNormalS
2026-06-23Ferritin [Mass/volume] in Serum or Plasma31ng/mL30-150 ng/mLNormalS
2026-06-23Platelets [#/volume] in Blood by Automated count24110*3/uL150-400 10*3/uLNormalS
2026-06-23Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO128mg/dL<=139 mg/dLNormalS
2026-06-23Fetal Body weight estimated by US760gAbout the 55th centile for 25 weeksNormalS
2026-06-23Fetal Body weight estimated by US720gAbout the 40th centile for 25 weeks; discordance 5 percentNormalS
2026-06-23Total score [EPDS]7{score}S

Physical Exam

Vital signs recorded on 2026-06-23; see the Vital Signs section. [S]

SystemFinding
GeneralWell
AbdomenFundal height 29 cm, consistent with twins at 25 weeks; non-tender
FetalScan: estimated weights 760 and 720 g, discordance 5 percent; normal fluid; fetal hearts 144 and 140 per minute
ExtremitiesNo edema
Urine dipstickProtein negative

Problems

ProblemClinical statusVerificationCodeProvenance
Uterus larger than dates in early pregnancy: 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size; nausea and vomiting heavier than in her first pregnancy; no bleeding; cause not yet known (multiple pregnancy, dating error, fibroids, or molar pregnancy)resolvedconfirmed O26.841S — Synthetic presenting finding anchored to the documented conception in the winter of 41 to 40 BC; it resolves when the ultrasound explains it.
Nausea and vomiting of pregnancy, moderate (PUQE score 9); keeping fluids down; no weight loss or ketonuriaresolvedconfirmed O21.9S — Synthetic; nausea is common and often heavier in early pregnancy with a large uterus.
Iron deficiency anemia in pregnancy: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mLactiveconfirmed O99.011S — Synthetic finding; it echoes no documented diagnosis.
Twin pregnancy, dichorionic diamniotic, second pregnancy (gravida 2, para 1): two live fetuses with a thick dividing membrane and a twin-peak (lambda) sign at 11 weeks; dated by her last period, confirmed by the crown-rump lengthsactiveconfirmed O30.041S — Synthetic modern diagnosis anchored to the documented twins of 40 BC; chorionicity is a modern finding and makes no claim about her real pregnancy.
Acute viral gastroenteritis at 22 weeks in a twin pregnancy, with mild dehydration and painless tightenings; no preterm labor (cervical length 39 mm); resolved with oral rehydrationresolvedconfirmed O98.512S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach the assessment of tightenings and dehydration in a twin pregnancy; it echoes no documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure and urine proteinEvery prenatal visitCompleted today108/66 mmHg; urine protein negative
ExaminationFetal hearts and fundal heightEvery prenatal visitCompleted todayFetal hearts 144 and 140 per minute; fundal height 29 cm
ExaminationWeight gain (about 17 to 25 kg for twins from a normal BMI)Every prenatal visitCompleted today64.2 kg, up 6.2 kg since intake
ImagingGrowth scan with discordanceEvery four weeks from about 20 to 24 weeks in a dichorionic twin pregnancyCompleted today760 and 720 g; discordance 5 percent; normal fluid and umbilical artery Doppler
LaboratoryHemoglobin and ferritinAt intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimesterCompleted todayHemoglobin 10.9 g/dL and ferritin 31 ng/mL; platelets 241
LaboratoryGestational diabetes screen (one-hour 50 g glucose challenge)At 24 to 28 weeksCompleted today128 mg/dL, below the 140 mg/dL threshold
LaboratoryAntibody screen and anti-D at 28 weeksAt 28 weeks for RhD-negative patientsNot indicatedRhD positive with a negative antibody screen at intake
SurveyPerinatal mood screen (EPDS)Each trimesterCompleted today7; item 10 scored 0
Medication safetyLow-dose aspirinDaily from 12 weeks until delivery; review at every visitCompleted todayTaken nightly; held for one night during the gastroenteritis; no bleeding
Medication safetyTdap vaccineOnce at 27 to 36 weeks in every pregnancyDueAt the next visit
Self-managementPreterm labor warning signsEvery prenatal visitCompleted todayNo tightenings since the gastroenteritis; warning signs reviewed

Goal progress:

Guideline basis: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021); Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021); Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021); ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus (2018); Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 4 (2023)

Follow-up: Prenatal visit with the growth scan at 29 weeks, then every two weeks. Next scheduled visit 2026-08-18: prenatal visit at 33 weeks: growth scan, Tdap, and the delivery plan. [S]